Medtronic (NYSE:MDT) said today that it won CE Mark approval in the European Union for its line of quadripolar, MRI-safe cardiac resynchronization therapy pacemakers. The approval covers Medtronic’s Percepta, Serena and Solara devices, the Fridley, Minn.-based company said. The devices are slated to the hit the European market in March. “With the addition of quadripolar CRT-P […]
Medtronic
Abbott denies reports it will bail on India’s high-end stent market
Abbott (NYSE:ABT) yesterday denied reports that it’s pulling its high-end coronary stents from India’s market, after the government there put price caps in place for a variety of medical devices and drugs, including stents. India’s National Pharmaceutical Pricing Authority last week issued an order capping the price of stents at about $108 (Rs 7,260) for bare-metal devices […]
Medtronic’s Q3 numbers top estimates
Medtronic (NYSE:MDT) today beat the consensus forecast with its fiscal 3rd-quarter results, despite a -25% profit slide, sending shares up slightly in pre-market trading. The Fridley, Minn.-based medical device giant posted profits of $821 million, or 59¢ per share, on sales of $7.28 billion for the 3 months ended Jan. 27. That’s a -25.0% bottom-line slide […]
7 medtech stories we missed: Feb. 17, 2017
Several companies released diabetes study results this week, while companies like BioTime closed on their public offerings and Pixium implanted its first bionic eye. Here are 7 medtech stories we missed this week, but were still worth mentioning. 1. Insulet touts glucose control study Insulet Corp. announced the results from its first feasibility study of its Omnipod […]
How virtual and mixed reality are changing drug delivery and device design
Kai Worrell believes that virtual and mixed reality may change the way companies design medical devices, and he’s putting that idea into practice. “We think it’s going to transform the way we do feasibility testing and cognitive walk-through simulations,” he said. “We think it’s going to help us understand the cognition of our users, clinical […]
Japan approves Medtronic’s Micra leadless pacemaker
Medtronic (NYSE:MDT) said today that Japanese regulators approved its Micra leadless pacemaker, which it claims as the world’s smallest pacemaker. At 1/10th the size of a conventional pacemaker, or roughly the size of a large vitamin, Micra is designed to be implanted via catheter in the right ventricle to deliver single-chamber pacing. The device has an estimated 12-year […]
Medtronic launches Signia stapler
Medtronic (NYSE:MDT) said today it launched its Signia stapling system in the US, Western Europe and Japan. The newly launched stapler from the Fridley, Minn.-based company includes Adaptive Firing technology which adjusts the stapler’s speed based on tissue variability measurements for more consistent staple lines. The device also includes 1-hand staple firing to allow for […]
FDA expands indication for Medtronic’s Freezor Xtra cryoablation catheter
Medtronic (NYSE:MDT) said today that it won an expanded indication from the FDA for its Freezor Xtra cryoablation catheter for treating atrioventricular nodal re-entrant tachycardia. Fridley, Minn.-based Medtronic said the Freezor Xtra catheter is a flexible, single-use device used to freeze cardiac tissue and block unnecessary electrical signals within the heart. “Medtronic is pleased with […]
Medtronic wins temporary reprieve in ex-rep’s whistleblower suit
Medtronic (NYSE:MDT) got a temporary reprieve this week in a whistleblower lawsuit brought by a former sales rep over its Verte-Stack spine implants Bryan Shapiro, a former rep for Medtronic’s spine business, filed a whistleblower lawsuit in July 2016, alleging that Medtronic and its subsidiaries “engaged in a fraudulent scheme that caused the Medicare and Medicaid Programs to pay […]
FDA expands indication for Medtronic’s OsteoCool
Medtronic (NYSE:MDT) said today that it won an expanded indication from the FDA for its OsteoCool RF ablation device for palliative treatment of metastases in all bony anatomy. The OsteoCool RF device was previously indicated for use in the spine, according to Fridley, Minn.-based Medtronic. It’s used to ablate metastatic bone tumors. Medtronic acquired the technology […]
Baxter snags Medtronic vet Oesterle | Personnel Moves | February 14, 2017
Baxter (NYSE:BAX) announced earlier this month it tapped former Medtronic (NYSE:MDT) senior VP of medicine and tech Stephen Oesterle for its board of directors, bringing the total seats on the board to 12. Oesterle moved to the venture capital firm New Enterprise Associates last Sept from his position at Medtronic. Before moving to NEA, Oesterle served […]